
University of California,
San Diego (UCSD)
Rebecca and John Moores UCSD
Cancer Center
La Jolla, CA
The Burnham Institute
La Jolla, CA
Dana Farber Cancer Institute
Harvard Medical School
Boston, MA
Johns Hopkins University
Oncology Center
Baltimore, MD
Long Island Jewish Medical
Center
Division of Hematology/Oncology
New Hyde Park, NY
M.D. Anderson Cancer Center
Houston, TX
Ohio State University
Cancer Center
Columbus, Ohio
Barts Cancer Centre of
Excellence
Barts Hospital
West Smithfield, London
Mayo Clinic
Rochester, MN

Barts Hospital,
West Smithfield,
London EC1A 7BEDana-Farber Cancer Institute
http://www.bartscancercentre.org
Dr. John Gribben is an internationally recognized translational cancer researcher. He is the author of more than 175 manuscripts and book chapters. He is the PI on several peer-reviewed grants from NIH and is a founder member of the Chronic Lymphocytic Leukemia Consortium. He directs studies of CLL at Dana-Farber/Partners Cancer Center and is the Director of the Eskandarian CLL Research Laboratories at the Dana-Farber Cancer Institute. He is a member of numerous academic societies, including the American Society for Clinical Investigation and is a member of Subcommittee D of the National Cancer Institute.
Research Interests